GDWL
Goldenwell Biotech receives legal counsel's support for Form 8-K filing.
Goldenwell Biotech's law firm, Michael Gillespie & Associates, PLLC, affirmed the company's statements in the included Form 8-K dated September 28, 2026.
GDWL news
Latest 2 stories · newest Sep 29, 2026
GDWL
Auditor Michael Gillespie & Associates agrees with Item 4.02 disclosures
Michael Gillespie & Associates, PLLC has confirmed agreement with Goldenwell Biotech's statements regarding auditor changes filed on May 26, 2026. This auditor acknowledgment letter is a standard regulatory requirement when companies change accounting firms.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same GDWL feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/GDWL/newsSTART FREE